A Phase 3 interventional study of DWP14012 40mg (Fexuprazan) and Lansoprazole 30mg in Gastric Ulcer, sponsored by Daewoong Pharmaceutical Co. LTD.. Not yet recruiting at 2 sites in 2 countries. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-07-28.
Sponsored by Daewoong Pharmaceutical Co. LTD. · Phase 3, Interventional, and Treatment
A Multinational, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group, Phase 3 Study to Evaluate the Efficacy and Safety of DWP14012 in Participants with Gastric Ulcer
116 studies on the registry are indexed under Stomach Ulcer; 13 are open to participants now.
This study's planned enrollment of 384 is above the median of 298 across 88 interventional studies indexed under Stomach Ulcer.
Browse Stomach Ulcer studies →Daewoong Pharmaceutical Co. LTD. is the lead sponsor of 200 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Relapsed and refractory
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: DWP14012 40mg (Fexuprazan)
Drug: Lansoprazole 30mg
DWP14012 40mg(Fexuprazan) + placebo of Lansoprazole
Lansoprazole 30mg + Placebo of DWP14012 40mg
Cumulative gastric ulcer healing rate confirmed by upper gastrointestinal endoscopy through Week 8
Time frame: Week 8
Gastric ulcer healing rate confirmed by upper gastrointestinal endoscopy at Week 4
Time frame: Week 4
Gastric ulcer healing rate confirmed by upper gastrointestinal endoscopy at Week 4 according to H. pylori infection status.
Time frame: Week 4
Cumulative gastric ulcer healing rate confirmed by upper gastrointestinal endoscopy through Week 8 according to H. pylori infection status.
Time frame: Week 8
Changes in NDI scores at Weeks 4 and 8.
Time frame: Week 4 and Week 8
Changes in the number of gastric ulcers at Weeks 4 and 8.
Time frame: Week 4 and Week 8
Change from baseline in gastric ulcer size assessed by upper gastrointestinal endoscopy
Time frame: Week 4 and Week 8
Percentage change from baseline in gastric ulcer size assessed by upper gastrointestinal endoscopy at Week 4 and Week 8
Time frame: Week 4 and Week 8
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Fexuprazan
Daewoong Pharmaceutical Co. LTD. →